British Journal of Cancer - Issue - nature.com science feeds

The DNA damage response in viral-induced cellular transformation

P A Nikitin — 2012-01-31

The DNA damage response in viral-induced cellular transformation

British Journal of Cancer 106, 429 (31 January 2012). doi:10.1038/bjc.2011.612

Authors: P A Nikitin & M A Luftig

Risk profiles of prostate cancers identified from UK primary care using national referral guidelines

H Serag — 2012-01-31

Risk profiles of prostate cancers identified from UK primary care using national referral guidelines

British Journal of Cancer 106, 436 (31 January 2012). doi:10.1038/bjc.2011.596

Authors: H Serag, S Banerjee, K Saeb-Parsy, S Irving, K Wright, S Stearn, A Doble & V J Gnanapragasam

Brain metastases free survival differs between breast cancer subtypes

A Berghoff — 2012-01-31

Brain metastases free survival differs between breast cancer subtypes

British Journal of Cancer 106, 440 (31 January 2012). doi:10.1038/bjc.2011.597

Authors: A Berghoff, Z Bago-Horvath, C De Vries, P Dubsky, U Pluschnig, M Rudas, A Rottenfusser, M Knauer, H Eiter, F Fitzal, K Dieckmann, R M Mader, M Gnant, C C Zielinski, G G Steger, M Preusser & R Bartsch

Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection

G M Clifford — 2012-01-31

Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection

British Journal of Cancer 106, 447 (31 January 2012). doi:10.1038/bjc.2011.558

Authors: G M Clifford, M Lise, S Franceschi, M Egger, C Bouchardy, D Korol, F Levi, S Ess, G Jundt, G Wandeler, J Fehr, P Schmid, M Battegay, E Bernasconi, M Cavassini, A Calmy, O Keiser & F Schöni-Affolter

Randomised phase-II trial of CAPIRI (capecitabine, irinotecan) plus bevacizumab vs FOLFIRI (folinic acid, 5-fluorouracil, irinotecan) plus bevacizumab as first-line treatment of patients with unresectable/metastatic colorectal cancer (mCRC)

J Souglakos — 2012-01-31

Randomised phase-II trial of CAPIRI (capecitabine, irinotecan) plus bevacizumab vs FOLFIRI (folinic acid, 5-fluorouracil, irinotecan) plus bevacizumab as first-line treatment of patients with unresectable/metastatic colorectal cancer (mCRC)

British Journal of Cancer 106, 453 (31 January 2012). doi:10.1038/bjc.2011.594

Authors: J Souglakos, N Ziras, S Kakolyris, I Boukovinas, N Kentepozidis, P Makrantonakis, S Xynogalos, Ch Christophyllakis, Ch Kouroussis, L Vamvakas, V Georgoulias & A Polyzos

Intraperitoneal clearance as a potential biomarker of cisplatin after intraperitoneal perioperative chemotherapy: a population pharmacokinetic study

B Royer — 2012-01-31

Intraperitoneal clearance as a potential biomarker of cisplatin after intraperitoneal perioperative chemotherapy: a population pharmacokinetic study

British Journal of Cancer 106, 460 (31 January 2012). doi:10.1038/bjc.2011.557

Authors: B Royer, E Kalbacher, S Onteniente, V Jullien, D Montange, S Piedoux, A Thiery-Vuillemin, D Delroeux, S Pili-Floury, E Guardiola, M Combe, P Muret, V Nerich, B Heyd, B Chauffert, J-P Kantelip & X Pivot

Phase I study to assess the safety and tolerability of olaparib in combination with bevacizumab in patients with advanced solid tumours

E Dean — 2012-01-31

Phase I study to assess the safety and tolerability of olaparib in combination with bevacizumab in patients with advanced solid tumours

British Journal of Cancer 106, 468 (31 January 2012). doi:10.1038/bjc.2011.555

Authors: E Dean, M R Middleton, T Pwint, H Swaisland, J Carmichael, P Goodege-Kunwar & M Ranson

BPR1J-097, a novel FLT3 kinase inhibitor, exerts potent inhibitory activity against AML

W-H Lin — 2012-01-31

BPR1J-097, a novel FLT3 kinase inhibitor, exerts potent inhibitory activity against AML

British Journal of Cancer 106, 475 (31 January 2012). doi:10.1038/bjc.2011.564

Authors: W-H Lin, W-T Jiaang, C-W Chen, K-J Yen, S-Y Hsieh, S-C Yen, C-P Chen, K-Y Chang, C-Y Chang, T-Y Chang, Y-L Huang, T-K Yeh, Y-S Chao, C-T Chen & J T-A Hsu

The cyclin-dependent kinase inhibitor p57Kip2 is epigenetically regulated in carboplatin resistance and results in collateral sensitivity to the CDK inhibitor seliciclib in ovarian cancer

H M Coley — 2012-01-31

The cyclin-dependent kinase inhibitor p57Kip2 is epigenetically regulated in carboplatin resistance and results in collateral sensitivity to the CDK inhibitor seliciclib in ovarian cancer

British Journal of Cancer 106, 482 (31 January 2012). doi:10.1038/bjc.2011.566

Authors: H M Coley, N A M Safuwan, P Chivers, E Papacharalbous, T Giannopoulos, S Butler-Manuel, K Madhuri, D P Lovell & T Crook

Irreversible electroporation on the small intestine

M A Phillips — 2012-01-31

Irreversible electroporation on the small intestine

British Journal of Cancer 106, 490 (31 January 2012). doi:10.1038/bjc.2011.582

Authors: M A Phillips, R Narayan, T Padath & B Rubinsky

Combination of a fusogenic glycoprotein, pro-drug activation and oncolytic HSV as an intravesical therapy for superficial bladder cancer

G R Simpson — 2012-01-31

Combination of a fusogenic glycoprotein, pro-drug activation and oncolytic HSV as an intravesical therapy for superficial bladder cancer

British Journal of Cancer 106, 496 (31 January 2012). doi:10.1038/bjc.2011.577

Authors: G R Simpson, A Horvath, N E Annels, T Pencavel, S Metcalf, R Seth, P Peschard, T Price, R S Coffin, H Mostafid, A A Melcher, K J Harrington & H S Pandha

A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker

L Khoja — 2012-01-31

A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker

British Journal of Cancer 106, 508 (31 January 2012). doi:10.1038/bjc.2011.545

Authors: L Khoja, A Backen, R Sloane, L Menasce, D Ryder, M Krebs, R Board, G Clack, A Hughes, F Blackhall, J W Valle & C Dive

Potential role of a navigator gene NAV3 in colorectal cancer

E Carlsson — 2012-01-31

Potential role of a navigator gene NAV3 in colorectal cancer

British Journal of Cancer 106, 517 (31 January 2012). doi:10.1038/bjc.2011.553

Authors: E Carlsson, A Ranki, L Sipilä, L Karenko, W M Abdel-Rahman, K Ovaska, L Siggberg, U Aapola, R Ässämäki, V Häyry, K Niiranen, M Helle, S Knuutila, S Hautaniemi, P Peltomäki & K Krohn

Microcalcifications in breast cancer: novel insights into the molecular mechanism and functional consequence of mammary mineralisation

R F Cox — 2012-01-31

Microcalcifications in breast cancer: novel insights into the molecular mechanism and functional consequence of mammary mineralisation

British Journal of Cancer 106, 525 (31 January 2012). doi:10.1038/bjc.2011.583

Authors: R F Cox, A Hernandez-Santana, S Ramdass, G McMahon, J H Harmey & M P Morgan

Gene expression profiles of gliomas in formalin-fixed paraffin-embedded material

L A M Gravendeel — 2012-01-31

Gene expression profiles of gliomas in formalin-fixed paraffin-embedded material

British Journal of Cancer 106, 538 (31 January 2012). doi:10.1038/bjc.2011.547

Authors: L A M Gravendeel, J J de Rooi, P H C Eilers, M J van den Bent, P A E Sillevis Smitt & P J French

The frequency of T regulatory cells modulates the survival of multiple myeloma patients: detailed characterisation of immune status in multiple myeloma

K Giannopoulos — 2012-01-31

The frequency of T regulatory cells modulates the survival of multiple myeloma patients: detailed characterisation of immune status in multiple myeloma

British Journal of Cancer 106, 546 (31 January 2012). doi:10.1038/bjc.2011.575

Authors: K Giannopoulos, W Kaminska, I Hus & A Dmoszynska

Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors

Y Xu — 2012-01-31

Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors

British Journal of Cancer 106, 553 (31 January 2012). doi:10.1038/bjc.2011.568

Authors: Y Xu, T Brenn, E R S Brown, V Doherty & D W Melton

ADM3, TFF3 and LGALS3 are discriminative molecular markers in fine-needle aspiration biopsies of benign and malignant thyroid tumours

S Karger — 2012-01-31

ADM3, TFF3 and LGALS3 are discriminative molecular markers in fine-needle aspiration biopsies of benign and malignant thyroid tumours

British Journal of Cancer 106, 562 (31 January 2012). doi:10.1038/bjc.2011.578

Authors: S Karger, K Krause, M Gutknecht, K Schierle, D Graf, F Steinert, H Dralle & D Führer

Standard errors of non-standardised and age-standardised relative survival of cancer patients

L Jansen — 2012-01-31

Standard errors of non-standardised and age-standardised relative survival of cancer patients

British Journal of Cancer 106, 569 (31 January 2012). doi:10.1038/bjc.2011.560

Authors: L Jansen, T Hakulinen & H Brenner

Estimating the asbestos-related lung cancer burden from mesothelioma mortality

V McCormack — 2012-01-31

Estimating the asbestos-related lung cancer burden from mesothelioma mortality

British Journal of Cancer 106, 575 (31 January 2012). doi:10.1038/bjc.2011.563

Authors: V McCormack, J Peto, G Byrnes, K Straif & P Boffetta

Blood leukocyte Alu and LINE-1 methylation and gastric cancer risk in the Shanghai Women's Health Study

Y Gao — 2012-01-31

Blood leukocyte Alu and LINE-1 methylation and gastric cancer risk in the Shanghai Women's Health Study

British Journal of Cancer 106, 585 (31 January 2012). doi:10.1038/bjc.2011.562

Authors: Y Gao, A Baccarelli, X O Shu, B-T Ji, K Yu, L Tarantini, G Yang, H-L Li, L Hou, N Rothman, W Zheng, Y-T Gao & W-H Chow

Alcohol intake and mortality among women with invasive breast cancer

H R Harris — 2012-01-31

Alcohol intake and mortality among women with invasive breast cancer

British Journal of Cancer 106, 592 (31 January 2012). doi:10.1038/bjc.2011.561

Authors: H R Harris, L Bergkvist & A Wolk

Dietary fat intake and risk of ovarian cancer in the NIH-AARP Diet and Health Study

M M Blank — 2012-01-31

Dietary fat intake and risk of ovarian cancer in the NIH-AARP Diet and Health Study

British Journal of Cancer 106, 596 (31 January 2012). doi:10.1038/bjc.2011.572

Authors: M M Blank, N Wentzensen, M A Murphy, A Hollenbeck & Y Park

Red and processed meat consumption and risk of pancreatic cancer: meta-analysis of prospective studies

S C Larsson — 2012-01-31

Red and processed meat consumption and risk of pancreatic cancer: meta-analysis of prospective studies

British Journal of Cancer 106, 603 (31 January 2012). doi:10.1038/bjc.2011.585

Authors: S C Larsson & A Wolk

Meat consumption and the risk of incident distal colon and rectal adenoma

L M Ferrucci — 2012-01-31

Meat consumption and the risk of incident distal colon and rectal adenoma

British Journal of Cancer 106, 608 (31 January 2012). doi:10.1038/bjc.2011.549

Authors: L M Ferrucci, R Sinha, W-Y Huang, S I Berndt, H A Katki, R E Schoen, R B Hayes & A J Cross